Potentially inappropriate medicines in elderly hospitalised patients according to the EU(7)-PIM list, STOPP version 2 criteria and comprehensive protocol
Authors:
- 12 April 2017
- journal article
- pharmacoepidemiology and-prescription
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 73 (8) , 991-999
Abstract
The aim of this study was to measure the prevalence of potentially inappropriate medications (PIMs) by using the EU(7)-PIM list, STOPP (Screening Tool of Older Persons’ potentially inappropriate Prescriptions) version 2 criteria and the new comprehensive protocol.Keywords
This publication has 50 references indexed in Scilit:
- Potentially Inappropriate Prescribing in Patients on Admission and Discharge from an Older Peoples’ Unit of an Acute UK HospitalDrugs & Aging, 2013
- Inappropriate prescribing in the hospitalized elderly patient: Defining the problem, evaluation tools, and possible solutionsClinical Interventions in Aging, 2010
- Inappropriate prescribing and adverse drug events in older peopleBMC Geriatrics, 2009
- The Norwegian General Practice (NORGEP) criteria for assessing potentially inappropriate prescriptions to elderly patientsScandinavian Journal of Primary Health Care, 2009
- STOPP (Screening Tool of Older Persons' potentially inappropriate Prescriptions): application to acutely ill elderly patients and comparison with Beers' criteriaAge and Ageing, 2008
- Potentially inappropriate medications in the elderly: a French consensus panel listEuropean Journal of Clinical Pharmacology, 2007
- Is inappropriate medication use a major cause of adverse drug reactions in the elderly?British Journal of Clinical Pharmacology, 2006
- Impact of inappropriate drug use among hospitalized older adultsEuropean Journal of Clinical Pharmacology, 2005
- Adverse Drug Reactions in an Elderly Hospitalised PopulationDrugs & Aging, 2005
- Frequency and risk factors of potentially inappropriate medication use in a community-dwelling elderly population: results from the 3C StudyEuropean Journal of Clinical Pharmacology, 2004